Evonik
Tuesday, October 06, 2020
10:00 a.m. EDT / 4:00 p.m. CEST

Microparticle-based drug products: Best practices for processing and fill-finish

Back to overview

Overview

This webinar, co-presented by Evonik Health Care and Powder Systems Ltd (PSL), will discuss common manufacturing challenges associated with the downstream processing and filling of polymeric microparticles. These long-acting injectables require specialized equipment considerations and have significant scale-up challenges. They often also require specialized processing steps post-microparticle formation, such as filtration and drying. Critical considerations for the final fill and finish steps will be discussed, in particular in light of the potential need for aseptic processing of the resulting drug product.

Experts featuring this session

Jerod Price
Director Drug Delivery Operations
Vita
Jerod Price joined Evonik Health Care in May 2020 as Director of Drug Delivery Manufacturing in Birmingham, Alabama, USA. He has more than 25 years of experience with Amgen, Inc. in operational roles in the US, Netherlands, and Ireland. These roles at Amgen included operational and supervisory roles including Plant Manager and Operations Improvement Director. He has extensive experience in pharmaceutical manufacturing, process development, technical transfer, clinical and commercial operations, including aseptic operations, lyophilization, filling, capping, packaging, and including capital projects, validation, FDA/EMEA regulatory inspections successes, and product launches and commercialization. Jerod also has a strong background in continuous improvement methodologies, operational excellence, six sigma, long range planning, and business processes, including workforce strategy and organizational design. Jerod has a B.A in Biological Sciences from the University of California Santa Cruz.
Pierre Landais
Director Global Business Development
Vita
As Global Business Development Director at PSL, Pierre supports pharmaceutical drug manufacturers with GMP advice in regards to the common manufacturing challenges associated with the aseptic production and processing of their polymeric microparticle-based drugs.

Overall, he has more than ten years of global industry experience in the manufacturing scale-up and process development of polymeric microparticle products for extended release across Europe, Asia-Pacific and North America.

Pierre holds a Master’s degree in Industrial Engineering and Business Management from HEI in France and Kings College in London.

Register now

Details

Webinar language
English

Venue

Online

Questions?

Julia Born
Market Communications Health Care
+49 6151 18 4984 E-Mail
Register now
Evonik Health Care
Company Information
Legal Notice
Privacy Policy